ADMA Biologics, Inc. (ADMA) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
ADMA Biologics, Inc. · Health Care · ref. ETF XLV · 53 calls · price $10.31
What the company does: ADMA Biologics, Inc. functions as a biopharmaceutical company specializing in the development, manufacturing, and commercialization of advanced biologic therapies derived from blood plasma.
📈 ADMA Biologics, Inc. (ADMA) stock price
$10.31-31.0% over range
Oct 14, 25low $7.6 · high $20.38Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
100% recommend buying · 2 analysts
📊 JPI status : ADMA Biologics, Inc. has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 ADMA price target & analyst consensus — price $10.31
The price target · all analysts combined (2 targets)
Highest target · 1 firm of 2$18+74.6%
Median target · of 2 targets$17.5+69.7%
Lowest target · 1 firm of 2$17+64.9%
Current price$10.31
⭐ What the most reliable analysts say
No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.
The consensus · 2 ratings (last 6 months)
Strong Buy00%
Buy2100%
Hold00%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 ADMA price target all
All 53 calls, one by one, with our verdict on each firm.
→ See all 53 targets, analyst by analyst💡 The best analysts on ADMA most reliable
Their real reliability on ADMA, firm by firm: who was right, who was wrong.
→ See their reliability on ADMAAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about ADMA Biologics, Inc.? The JPI assistant answers using our backtest data.
🏛️ ADMA Biologics, Inc. insider buying: who's buying and how much › open the full page
1 insider bought3 buys / 6 mo $251k
🔎 Detailed analyses
✅ Historical analyst reliability on ADMA
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Mizuho ↗ | 100% | +102.2% | 6 |
| HC Wainwright & Co. ↗ | 78% | +96.2% | 18 |
| Cantor Fitzgerald ↗ | 67% | +113.3% | 9 |
| Raymond James ↗ | 45% | +44.6% | 11 |
| Oppenheimer ↗ | 0% | -31.4% | 3 |
| Maxim Group | 0% | -42.6% | 2 |
📊 What $1,000 invested in ADMA Biologics, Inc. would be worth › open the full page
In short — $1,000 invested in ADMA Biologics, Inc. 10 years ago would be worth $1,099 today, i.e. +1%/yr on average. Best year: 2024 (+279%), worst: 2020 (-51%). Price performance, excluding dividends.
If I'd invested $1,000 in ADMA Biologics, Inc.
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $517 | -48% |
| 3 years ago | $2,286 | +129% |
| 5 years ago | $4,549 | +355% |
Return by year (ADMA Biologics, Inc.)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -51% | $486 (-51%) |
| 2025 | +6% | $517 (-48%) |
| 2024 | +279% | $1,962 (+96%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on ADMA Biologics, Inc.
Loading news…
📋 All analyst calls on ADMA
Filtered on — · ✕ show all
▲ Outperform · 🎯$17
Price at call : $8.81 — upside +93%
Today : $10.31 — upside +65%
🎯 on ADMA : 100% (6 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
in progress (365j)
matures : Jul 15, 27
matures : Jul 15, 27
Canaccord Genuity ↗
May 7, 26
▲ Buy · 🎯$18
Price at call : $8.17 — upside +120%
Today : $10.31 — upside +75%
🎯 on ADMA : no call matured yet · 📊 on Health : 39.9% · -0.9% (148 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
▲ Outperform · 🎯$20
Price at call : $8.47 — upside +136%
Today : $10.31 — upside +94%
🎯 on ADMA : 100% (6 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
Canaccord Genuity ↗
Apr 21, 26
▲ Buy · 🎯$21
Price at call : $10.95 — upside +92%
Today : $10.31 — upside +104%
🎯 on ADMA : no call matured yet · 📊 on Health : 39.9% · -0.9% (148 calls)
in progress (365j)
matures : Apr 21, 27
matures : Apr 21, 27
▲ Outperform · 🎯$24
Price at call : $10.49 — upside +129%
Today : $10.31 — upside +133%
🎯 on ADMA : 100% (6 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
in progress (365j)
matures : Apr 13, 27
matures : Apr 13, 27
Cantor Fitzgerald ↗
Mar 26, 26
■ Neutral neutral · not a buy
🎯 on ADMA : 67% (9 calls matureds) · 📊 on Health : 50% · +13.4% (168 calls)
in progress (365j)
matures : Mar 26, 27
matures : Mar 26, 27
Raymond James ↗
May 8, 25
▲ Strong Buy · 🎯$32
Price at call : $19.98 — upside +60%
Today : $10.31 — upside +210%
Expected +60% · Actual -61% · Reason (≥ +15%) : ✗ No
🎯 on ADMA : 50% (8 calls matureds) · 📊 on Health : 39.7% · -2.1% (219 calls)
-60.6%
stock -61% · XLV +8%
matured May 8, 26
Cantor Fitzgerald ↗
Mar 4, 25
▲ Overweight · 🎯$25
Price at call : $17.68 — upside +41%
Today : $10.31 — upside +142%
Expected +41% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on ADMA : 67% (9 calls matureds) · 📊 on Health : 50% · +13.4% (168 calls)
-11.2%
stock -11% · XLV +3%
matured Mar 4, 26
See the other 45 calls, newest to oldest
HC Wainwright & Co. ↗
Nov 8, 24
▲ Buy · 🎯$26
Price at call : $22.48 — upside +16%
Today : $10.31 — upside +152%
Expected +16% · Actual -35% · Reason (≥ +15%) : ✗ No
🎯 on ADMA : 78% (18 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
-34.6%
stock -35% · XLV -1%
matured Nov 8, 25
Raymond James ↗
Nov 8, 24
▲ Strong Buy · 🎯$25
Price at call : $22.48 — upside +11%
Today : $10.31 — upside +142%
Expected +11% · Actual -35% · Reason (≥ +15%) : ✗ No
🎯 on ADMA : 50% (8 calls matureds) · 📊 on Health : 39.7% · -2.1% (219 calls)
-34.6%
stock -35% · XLV -1%
matured Nov 8, 25
HC Wainwright & Co. ↗
Oct 14, 24
▲ Buy · 🎯$18
Price at call : $16.37 — upside +10%
Today : $10.31 — upside +75%
Expected +10% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on ADMA : 78% (18 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
-8.7%
stock -9% · XLV -8%
matured Oct 14, 25
Cantor Fitzgerald ↗
Sep 20, 24
▲ Overweight · 🎯$20
Price at call : $20.03 — upside -0%
Today : $10.31 — upside +94%
Expected -0% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on ADMA : 67% (9 calls matureds) · 📊 on Health : 50% · +13.4% (168 calls)
-20.0%
stock -20% · XLV -12%
matured Sep 20, 25
HC Wainwright & Co. ↗
Aug 12, 24
▲ Buy · 🎯$18
Price at call : $16.45 — upside +9%
Today : $10.31 — upside +75%
Expected +9% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on ADMA : 78% (18 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+1.9%
stock +2% · XLV -12%
matured Aug 12, 25
Cantor Fitzgerald ↗
Aug 9, 24
▲ Overweight · 🎯$20
Price at call : $16.45 — upside +22%
Today : $10.31 — upside +94%
Expected +22% · Actual -0% · Reason (≥ +15%) : ✗ No
🎯 on ADMA : 67% (9 calls matureds) · 📊 on Health : 50% · +13.4% (168 calls)
-0.4%
stock -0% · XLV -13%
matured Aug 9, 25
Cantor Fitzgerald ↗
Jul 9, 24
▲ Overweight · 🎯$15
Price at call : $11.96 — upside +25%
Today : $10.31 — upside +45%
Expected +25% · Actual +53% · Reason (≥ +15%) : ✓ Yes
🎯 on ADMA : 67% (9 calls matureds) · 📊 on Health : 50% · +13.4% (168 calls)
+53.3%
stock +53% · XLV -7%
matured Jul 9, 25
▲ Buy · 🎯$14
Price at call : $10.71 — upside +31%
Today : $10.31 — upside +36%
Expected +31% · Actual +66% · Reason (≥ +15%) : ✓ Yes
🎯 on ADMA : 100% (6 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
+65.6%
stock +66% · XLV -9%
matured Jun 20, 25
Raymond James ↗
May 10, 24
▲ Strong Buy · 🎯$10
Price at call : $8.79 — upside +14%
Today : $10.31 — upside -3%
Expected +14% · Actual +133% · Reason (≥ +15%) : ✓ Yes
🎯 on ADMA : 50% (8 calls matureds) · 📊 on Health : 39.7% · -2.1% (219 calls)
+132.7%
stock +133% · XLV -5%
matured May 10, 25
Cantor Fitzgerald ↗
May 10, 24
▲ Overweight · 🎯$10
Price at call : $8.79 — upside +14%
Today : $10.31 — upside -3%
Expected +14% · Actual +133% · Reason (≥ +15%) : ✓ Yes
🎯 on ADMA : 67% (9 calls matureds) · 📊 on Health : 50% · +13.4% (168 calls)
+132.7%
stock +133% · XLV -5%
matured May 10, 25
HC Wainwright & Co. ↗
May 10, 24
▲ Buy · 🎯$10
Price at call : $8.81 — upside +14%
Today : $10.31 — upside -3%
Expected +14% · Actual +132% · Reason (≥ +15%) : ✓ Yes
🎯 on ADMA : 78% (18 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+132.1%
stock +132% · XLV -5%
matured May 10, 25
▲ Buy · 🎯$12
Price at call : $8.81 — upside +36%
Today : $10.31 — upside +16%
Expected +36% · Actual +132% · Reason (≥ +15%) : ✓ Yes
🎯 on ADMA : 100% (6 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
+132.1%
stock +132% · XLV -5%
matured May 10, 25
HC Wainwright & Co. ↗
Mar 26, 24
▲ Buy · 🎯$7.5
Price at call : $6.5 — upside +15%
Today : $10.31 — upside -27%
Expected +15% · Actual +203% · Reason (≥ +15%) : ✓ Yes
🎯 on ADMA : 78% (18 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+203.1%
stock +203% · XLV -1%
matured Mar 26, 25
▲ Buy · 🎯$10
Price at call : $5.72 — upside +75%
Today : $10.31 — upside -3%
Expected +75% · Actual +177% · Reason (≥ +15%) : ✓ Yes
🎯 on ADMA : 100% (6 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
+176.8%
stock +177% · XLV +2%
matured Mar 1, 25
Cantor Fitzgerald ↗
Feb 29, 24
▲ Overweight · 🎯$8
Price at call : $5.52 — upside +45%
Today : $10.31 — upside -22%
Expected +45% · Actual +187% · Reason (≥ +15%) : ✓ Yes
🎯 on ADMA : 67% (9 calls matureds) · 📊 on Health : 50% · +13.4% (168 calls)
+186.8%
stock +187% · XLV +2%
matured Feb 28, 25
HC Wainwright & Co. ↗
Feb 29, 24
▲ Buy · 🎯$6
Price at call : $5.36 — upside +12%
Today : $10.31 — upside -42%
Expected +12% · Actual +206% · Reason (≥ +15%) : ✓ Yes
🎯 on ADMA : 78% (18 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+205.8%
stock +206% · XLV +3%
matured Feb 28, 25
▲ Buy · 🎯$9
Price at call : $5.29 — upside +70%
Today : $10.31 — upside -13%
Expected +70% · Actual +205% · Reason (≥ +15%) : ✓ Yes
🎯 on ADMA : 100% (6 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
+205.5%
stock +205% · XLV +2%
matured Jan 21, 25
HC Wainwright & Co. ↗
Jan 9, 24
▲ Buy · 🎯$6
Price at call : $5.07 — upside +18%
Today : $10.31 — upside -42%
Expected +18% · Actual +266% · Reason (≥ +15%) : ✓ Yes
🎯 on ADMA : 78% (18 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+266.1%
stock +266% · XLV +0%
matured Jan 8, 25
Cantor Fitzgerald ↗
Dec 19, 23
▲ Overweight · 🎯$6
Price at call : $4.09 — upside +47%
Today : $10.31 — upside -42%
Expected +47% · Actual +338% · Reason (≥ +15%) : ✓ Yes
🎯 on ADMA : 67% (9 calls matureds) · 📊 on Health : 50% · +13.4% (168 calls)
+337.6%
stock +338% · XLV +3%
matured Dec 18, 24
HC Wainwright & Co. ↗
Nov 17, 23
▲ Buy · 🎯$5
Price at call : $3.97 — upside +26%
Today : $10.31 — upside -52%
Expected +26% · Actual +392% · Reason (≥ +15%) : ✓ Yes
🎯 on ADMA : 78% (18 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+392.2%
stock +392% · XLV +11%
matured Nov 16, 24
Cantor Fitzgerald ↗
Aug 10, 23
▲ Overweight · 🎯$6
Price at call : $4.48 — upside +34%
Today : $10.31 — upside -42%
Expected +34% · Actual +267% · Reason (≥ +15%) : ✓ Yes
🎯 on ADMA : 67% (9 calls matureds) · 📊 on Health : 50% · +13.4% (168 calls)
+267.2%
stock +267% · XLV +10%
matured Aug 9, 24
Raymond James ↗
Aug 10, 23
▲ Strong Buy · 🎯$6
Price at call : $4.48 — upside +34%
Today : $10.31 — upside -42%
Expected +34% · Actual +267% · Reason (≥ +15%) : ✓ Yes
🎯 on ADMA : 50% (8 calls matureds) · 📊 on Health : 39.7% · -2.1% (219 calls)
+267.2%
stock +267% · XLV +10%
matured Aug 9, 24
HC Wainwright & Co. ↗
Aug 10, 23
▲ Buy · 🎯$5
Price at call : $4.31 — upside +16%
Today : $10.31 — upside -52%
Expected +16% · Actual +270% · Reason (≥ +15%) : ✓ Yes
🎯 on ADMA : 78% (18 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+270.3%
stock +270% · XLV +11%
matured Aug 9, 24
HC Wainwright & Co. ↗
Mar 27, 23
▲ Buy · 🎯$4.5
Price at call : $3.32 — upside +36%
Today : $10.31 — upside -56%
Expected +36% · Actual +96% · Reason (≥ +15%) : ✓ Yes
🎯 on ADMA : 78% (18 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+95.8%
stock +96% · XLV +14%
matured Mar 26, 24
HC Wainwright & Co. ↗
Feb 8, 23
▲ Buy · 🎯$4.5
Price at call : $3.6 — upside +25%
Today : $10.31 — upside -56%
Expected +25% · Actual +46% · Reason (≥ +15%) : ✓ Yes
🎯 on ADMA : 78% (18 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+45.6%
stock +46% · XLV +10%
matured Feb 8, 24
HC Wainwright & Co. ↗
Jan 3, 23
▲ Buy · 🎯$4.5
Price at call : $3.87 — upside +16%
Today : $10.31 — upside -56%
Expected +16% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on ADMA : 78% (18 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+14.2%
stock +14% · XLV +2%
matured Jan 3, 24
▲ Buy · 🎯$6
Price at call : $3.27 — upside +83%
Today : $10.31 — upside -42%
Expected +83% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on ADMA : 100% (6 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
+14.4%
stock +14% · XLV -5%
matured Nov 10, 23
▲ Buy · 🎯$5
Price at call : $2.7 — upside +85%
Today : $10.31 — upside -52%
Expected +85% · Actual +19% · Reason (≥ +15%) : ✓ Yes
🎯 on ADMA : 100% (6 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
+18.9%
stock +19% · XLV +4%
matured Oct 13, 23
HC Wainwright & Co. ↗
Jul 25, 22
▲ Buy · 🎯$4
Price at call : $2.19 — upside +83%
Today : $10.31 — upside -61%
Expected +83% · Actual +69% · Reason (≥ +15%) : ✓ Yes
🎯 on ADMA : 78% (18 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+69.4%
stock +69% · XLV +4%
matured Jul 25, 23
Raymond James ↗
Nov 11, 21
▲ Strong Buy · 🎯$5
Price at call : $1.59 — upside +214%
Today : $10.31 — upside -52%
Expected +214% · Actual +106% · Reason (≥ +15%) : ✓ Yes
🎯 on ADMA : 50% (8 calls matureds) · 📊 on Health : 39.7% · -2.1% (219 calls)
+105.7%
stock +106% · XLV -0%
matured Nov 11, 22
Cantor Fitzgerald ↗
Nov 9, 21
▲ Overweight · 🎯$4.5
Price at call : $1.42 — upside +217%
Today : $10.31 — upside -56%
Expected +217% · Actual +74% · Reason (≥ +15%) : ✓ Yes
🎯 on ADMA : 67% (9 calls matureds) · 📊 on Health : 50% · +13.4% (168 calls)
+73.9%
stock +74% · XLV -1%
matured Nov 9, 22
Raymond James ↗
Oct 26, 21
▲ Outperform · 🎯$5
Price at call : $1.35 — upside +270%
Today : $10.31 — upside -52%
Expected +270% · Actual +108% · Reason (≥ +15%) : ✓ Yes
🎯 on ADMA : 50% (8 calls matureds) · 📊 on Health : 39.7% · -2.1% (219 calls)
+108.1%
stock +108% · XLV -1%
matured Oct 26, 22
HC Wainwright & Co. ↗
Aug 12, 21
▲ Buy · 🎯$6
Price at call : $1.51 — upside +297%
Today : $10.31 — upside -42%
Expected +297% · Actual +57% · Reason (≥ +15%) : ✓ Yes
🎯 on ADMA : 78% (18 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+57.0%
stock +57% · XLV +1%
matured Aug 12, 22
HC Wainwright & Co. ↗
Jul 6, 21
▲ Buy · 🎯$7
Price at call : $1.51 — upside +364%
Today : $10.31 — upside -32%
Expected +364% · Actual +44% · Reason (≥ +15%) : ✓ Yes
🎯 on ADMA : 78% (18 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+44.4%
stock +44% · XLV +1%
matured Jul 6, 22
Raymond James ↗
Mar 26, 21
▲ Outperform · 🎯$6
Price at call : $1.81 — upside +231%
Today : $10.31 — upside -42%
Expected +231% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on ADMA : 50% (8 calls matureds) · 📊 on Health : 39.7% · -2.1% (219 calls)
-2.8%
stock -3% · XLV +17%
matured Mar 26, 22
HC Wainwright & Co. ↗
Jan 4, 21
▲ Buy · 🎯$11
Price at call : $2.11 — upside +421%
Today : $10.31 — upside +7%
Expected +421% · Actual -32% · Reason (≥ +15%) : ✗ No
🎯 on ADMA : 78% (18 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
-32.2%
stock -32% · XLV +22%
matured Jan 4, 22
Raymond James ↗
Oct 1, 20
▲ Outperform · 🎯$7
Price at call : $2.23 — upside +214%
Today : $10.31 — upside -32%
Expected +214% · Actual -47% · Reason (≥ +15%) : ✗ No
🎯 on ADMA : 50% (8 calls matureds) · 📊 on Health : 39.7% · -2.1% (219 calls)
-46.6%
stock -47% · XLV +21%
matured Oct 1, 21
Oppenheimer ↗
May 7, 20
▲ Outperform · 🎯$7
Price at call : $2.41 — upside +190%
Today : $10.31 — upside -32%
Expected +190% · Actual -31% · Reason (≥ +15%) : ✗ No
🎯 on ADMA : 0% (2 calls matureds) · 📊 on Health : 47.4% · +5.9% (95 calls)
-30.9%
stock -31% · XLV +25%
matured May 7, 21
HC Wainwright & Co. ↗
Mar 16, 20
▲ Buy · 🎯$12
Price at call : $1.8 — upside +567%
Today : $10.31 — upside +16%
Expected +567% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on ADMA : 78% (18 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+17.2%
stock +17% · XLV +41%
matured Mar 16, 21
▲ Buy · 🎯$8
Price at call : $4.39 — upside +82%
Today : $10.31 — upside -22%
Expected +82% · Actual -35% · Reason (≥ +15%) : ✗ No
🎯 on ADMA : 0% (1 call matured) · 📊 on Health : 49.6% · +9.4% (137 calls)
-34.8%
stock -35% · XLV +15%
matured Jun 3, 20
Oppenheimer ↗
Apr 2, 19
▲ Outperform · 🎯$16
Price at call : $5.06 — upside +216%
Today : $10.31 — upside +55%
Expected +216% · Actual -51% · Reason (≥ +15%) : ✗ No
🎯 on ADMA : 0% (2 calls matureds) · 📊 on Health : 47.4% · +5.9% (95 calls)
-51.4%
stock -51% · XLV -7%
matured Apr 1, 20
HC Wainwright & Co. ↗
Oct 30, 18
▲ Buy · 🎯$17
Price at call : $5.36 — upside +217%
Today : $10.31 — upside +65%
Expected +217% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on ADMA : 78% (18 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
-8.4%
stock -8% · XLV +7%
matured Oct 30, 19
Chardan Capital
Jul 30, 18
▲ Buy · 🎯$10
Price at call : $6.28 — upside +59%
Today : $10.31 — upside -3%
Expected +59% · Actual -43% · Reason (≥ +15%) : ✗ No
🎯 on ADMA : 0% (1 call matured) · 📊 on Health : 81.2% · +55.3% (16 calls)
-42.5%
stock -43% · XLV +5%
matured Jul 30, 19
Maxim Group
Jul 27, 18
▲ Buy · 🎯$12
Price at call : $6.28 — upside +91%
Today : $10.31 — upside +16%
Expected +91% · Actual -43% · Reason (≥ +15%) : ✗ No
🎯 on ADMA : 0% (2 calls matureds) · 📊 on Health : 0% · -27.9% (5 calls)
-43.5%
stock -43% · XLV +5%
matured Jul 27, 19
Maxim Group
Jul 26, 18
▲ Buy · 🎯$12
Price at call : $6.09 — upside +97%
Today : $10.31 — upside +16%
Expected +97% · Actual -42% · Reason (≥ +15%) : ✗ No
🎯 on ADMA : 0% (2 calls matureds) · 📊 on Health : 0% · -27.9% (5 calls)
-41.7%
stock -42% · XLV +5%
matured Jul 26, 19
Frequently asked questions
Should I buy ADMA Biologics, Inc. stock?
This isn't buy advice. For ADMA Biologics, Inc., the analyst consensus is "Buy", with an average price target of $17.50 (+70% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (6 calls tracked on ADMA Biologics, Inc.). We show the numbers — you decide.
Is it too late to buy ADMA Biologics, Inc.? How high can it go?
The most bullish analyst target on ADMA Biologics, Inc. is $18.00 (+75% above today's price); the average is $17.50. That's the upside they see. Check how reliable those analysts have actually been on ADMA Biologics, Inc. on our site before trusting it.
Is ADMA Biologics, Inc. still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 6 analysts have a real record on ADMA Biologics, Inc., the best hitting 100% over 6 calls. Current consensus: "Buy". Make your call on data, not noise.
Will ADMA Biologics, Inc. stock recover (go back up)?
It's down from its high. We answer with the numbers — the analysts' 12-month target and what happened after its past drops: will ADMA stock recover (go back up)?
What has ADMA Biologics, Inc.'s past performance been?
Historical returns and a "how much if I had invested" calculator: ADMA performance & returns.
Are insiders buying ADMA stock?
Executives' and large holders' buys and sells, decoded: insider buying on ADMA.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX